HomePPCB • OTCMKTS
add
Propanc Biopharma Inc
Previous close
$4.15
Year range
$1.25 - $13.25
Market cap
48.19M USD
Avg Volume
2.06K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 53.13M | 12,523.63% |
Net income | -54.07M | -10,165.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -53.13M | -12,525.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.76K | 715.81% |
Total assets | 22.53M | 60,235.20% |
Total liabilities | 4.44M | 18.68% |
Total equity | 18.09M | — |
Shares outstanding | 11.61M | — |
Price to book | 2.66 | — |
Return on assets | -1,175.11% | — |
Return on capital | -1,620.79% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -54.07M | -10,165.30% |
Cash from operations | -136.20K | -32.47% |
Cash from investing | — | — |
Cash from financing | 187.48K | 181.32% |
Net change in cash | 36.13K | 155.22% |
Free cash flow | -42.73M | -38,661.59% |
About
Founded
2007
Website
Employees
2
